跳至主要内容
临床试验/NCT03916107
NCT03916107Unknown不适用

Comparison of Different Surgical Treatments for Severe Ptosis Correction RCT Study

Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
MRD (margin reflex distance)

研究概览

简要总结

Main research purposes of this research is to compare the therapeutic effect and safety of the superior levator muscle shortening combined with the tarsus resection and the traditional frontal muscle flap in the correction of severe ptosis.

Aside of above we also tend to explore the dose-effect relationship between the amount of levator muscle shortened/ tarsus resection and postoperative ptosis correction amount.So as to develop a more critical and specific guidelines for clinical treatment of ptosis.

So during the research we will recruiting patients with severe ptosis and randomly divide them into levator muscle and tarsus group and frontal muscle flap group, and follow up those patient 6 months post operation so as to evaluate the amount of correction and the side-symptoms.

详细描述

The ptosis is divided into light, medium and severe according to the difference in muscle strength of the upper levator muscle. According to the previous diagnosis and treatment criteria, for the mild and moderate ptosis, it is recommended to use the method of shortening or partial resection of the levator muscle. For severe patients, because the strength of the upper levator muscles are extremely weak, the function of the upper eye lid can only be reconstructed through the strength of the frontal muscles. So it is recommended to use the frontal muscle flap surgery for correct ptosis. However, compared with the levator levator shortening, the shortcoming of the frontal muscle suspension is to change the nature anatomical relationship of the upper eyelid, resulting in unnatural eye lid lines, obvious frontal lines, easy recurrence and other shortcomings. In the case, this therapy turns out not to be very satisfied.

Based on years of clinical experience in treating ptosis, our research team have tried to use the levator muscle shortening combined with the tarsus resection method for more than 10 years. We have successfully cured more than 1000 patients with severe ptosis and obtained good therapeutic effects. The results are summarized and the sequence is published in several international journals and is recognized by domestic and foreign counterparts. However, for the new procedure of levator muscle shortening combined with tarsus resection, there is currently no comparative study with traditional therapy, and it is impossible to objectively evaluate its efficacy. Secondly, how to improve the long-term effect of levator muscle shortening combined with tarsus resection, whether the eyelid morphology is satisfactory, and the recurrence rate has not been reported. In addition, because the tarsus plays an important role in the shape and function of the eye, including maintaining the function of the tarsus and keeping the cornea moist, etc., the effect of partial removal of the tarsus on the original tarsus function is also worthy of further investigation.

Based on the original clinical results, the project team designed a randomized controlled single-blind study to compare the efficacy and safety of the levator muscle shortening combined with the tarsal resection and the traditional frontal muscle flap in the correction of severe ptosis. At the same time, to explore the dose-effect relationship between the shortening of the levator muscle and the amount of tarsal resection and the amount of correction of the ptosis after operation, the surgical design is more precise and personalized, which provides a scientific basis for further development of clinical diagnosis and treatment guidelines.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • unilateral ptosis patient
  • the levator muscle strength less than 4mm
  • primary surgery
  • older than 3 years
  • ocular rectus muscle of good strength;

排除标准

  • patients who had undergone ptosis correction surgery
  • patients with neurological ptosis, senile ptosis or pseudo ptosis
  • patients with abnormal ocular function
  • patients with Marcus-Gunn syndromes
  • patients with severe systemic disease or intolerant to general anesthesia
  • patients or their parents cannot finish follow-up due to educational level or various other reasons.

研究组 & 干预措施

Frontal muscle flap

Active Comparator

干预措施: Frontalis flap (Procedure)

Levator muscle and tarsus resection

Experimental

干预措施: Levator muscle and tarsus resection (Procedure)

结局指标

主要结局

MRD (margin reflex distance)

时间窗: 6 months post the treatment

Measure the distance from the upper temporal margin to the point of reflection at the center of the cornea, while doctor shall make sure patient avoid looking up or using the frontal muscle to lift eyelids.

width of eyes

时间窗: 6 months post the treatment

Measure the width of eyes while doctor shall make sure patient avoid looking up or using the frontal muscle to lift eyelids.

levator muscle's strength

时间窗: 6 months post the treatment

Measuring the muscle strength: let the patient look straight ahead, the examiner presses the eyebrow arch horizontally with the thumb, interrupting the connection between the frontal muscle and the upper eyelids, and ask patient to look down. Then ask the patient to look up as much as they can, and the scale of this movement is the levator muscle strength. When a normal person does not use the frontal muscle, the average scale of the upper eye lids movement is 13.37±2.55mm. The muscle strength of the upper eye lids is generally divided into three levels. The good upper eye lids movement scale is 8mm, the medium is 4\~7mm, and the weak one is 0\~3mm.

次要结局

  • Numbers of patients having trichiasis;(6 months post the treatment)
  • Numbers of patients not completely corrected(6 months post the treatment)
  • Numbers of patients having corneal injury(6 months post the treatment)
  • Numbers of patients having conjunctival prolapse;(6 months post the treatment)
  • Numbers of patients having eye infection;(6 months post the treatment)
  • Numbers of patients having dry eye syndrome(6 months post the treatment)
  • Numbers of patients having orbital insufficiency(6 months post the treatment)

研究者

发起方
Shanghai Jiao Tong University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qing-FengLi Li,MD

MD, PhD, Professor, Head of the Department of Plastic and Reconstructive Surgery, Shanghai 9th People'sHospital

Shanghai Jiao Tong University School of Medicine

研究点 (1)

Loading locations...

相似试验